AnalystsJason McCarthyJason McCarthy's Stock Forecasts
AnalystsJason McCarthy
Analyst Ranking
Bottom 2%
#4492 out of 4555 analysts
Average Return
-16.96%
Win Rate
29%29 out of 101
Risk vs Reward
Poor
Good
Jason McCarthy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cassava Sciences IncSAVA | +508.00% | $7.75 | $47.12 | 2020-09-13 - 2021-09-13 | Strong Buy |
Inovio Pharmaceuticals IncINO | +293.89% | $31.44 | $123.84 | 2013-01-30 - 2014-01-31 | Strong Buy |
Biolife Solutions IncBLFS | +135.87% | $5.91 | $13.94 | 2017-11-09 - 2018-11-09 | Strong Buy |
Achieve Life Sciences IncACHV | +125.00% | $2.16 | $4.86 | 2022-11-15 - 2023-11-15 | Strong Buy |
Matinas Biopharma Holdings IncMTNB | +117.32% | $0.41 | $0.89 | 2018-07-09 - 2019-07-10 | Strong Buy |
Jason McCarthy Analyst Color
Get additional color on Jason McCarthy's coverage of popular stocks
Jason McCarthy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lipella Pharmaceuticals IncLIPO | 1 | Strong Buy | $2.00 | +178.55% | Initiates Coverage On | 11 days ago |
Rezolute IncRZLT | 1 | Strong Buy | $8.00 | +133.24% | Initiates Coverage On | 11 days ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $6.00 | +224.32% | Upgrades | 17 days ago |
Moleculin Biotech IncMBRX | 1 | Strong Buy | $20.00 | +330.11% | Maintains | 25 days ago |
Actinium Pharmaceuticals IncATNM | 1 | Strong Buy | $30.00 | +337.96% | Maintains | a month ago |
Belite Bio IncBLTE | 1 | Strong Buy | $60.00 | +79.48% | Initiates Coverage On | 4 months ago |
Avenue Therapeutics IncATXI | 1 | Strong Buy | $0.75 | +476.92% | Initiates Coverage On | 4 months ago |
Bionomics LimitedBNOX | 2 | Strong Buy | $10.00 | +921.45% | Maintains | 7 months ago |
Cyclo Therapeutics IncCYTH | 1 | Strong Buy | $4.00 | +244.83% | Upgrades | 7 months ago |
Gain Therapeutics IncGANX | 1 | Strong Buy | $10.00 | +214.47% | Initiates Coverage On | 7 months ago |
Genelux CorpGNLX | 1 | Strong Buy | $40.00 | +868.52% | Initiates Coverage On | 7 months ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | $4.00 | +203.03% | Initiates Coverage On | 7 months ago |
Vistagen Therapeutics IncVTGN | 4 | Strong Buy | $30.00 | +530.25% | Maintains | 7 months ago |
Galmed Pharmaceuticals LtdGLMD | 3 | Strong Buy | $4.00 | +972.39% | Upgrades | 9 months ago |
Kintara Therapeutics IncKTRA | 2 | Strong Buy | $14.00 | +11,470.25% | Upgrades | 9 months ago |
Immutep LtdIMMP | 2 | Strong Buy | $10.00 | +344.44% | Maintains | a year ago |
Tracon Pharmaceuticals IncTCON | 1 | Strong Buy | $60.00 | +2,961.22% | Maintains | a year ago |
Plus Therapeutics IncPSTV | 2 | Strong Buy | $12.00 | +636.20% | Maintains | a year ago |
Reviva Pharmaceuticals Holdings IncRVPH | 3 | Strong Buy | $18.00 | +496.03% | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $400.00 | +1.45% | Maintains | a year ago |
Contrafect CorpCFRXQ | 2 | Strong Buy | $3.00 | N/A | Upgrades | a year ago |
Panbela Therapeutics IncPBLA | 3 | Strong Buy | $900.00 | N/A | Upgrades | a year ago |
Zevra Therapeutics IncZVRA | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Aprea Therapeutics IncAPRE | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Unicycive Therapeutics IncUNCY | 2 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Nls Pharmaceutics LtdNLSP | 3 | Strong Buy | $4.00 | N/A | Upgrades | a year ago |
Onconetix IncONCO | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | a year ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Abvc Biopharma IncABVC | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Inovio Pharmaceuticals IncINO | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Gilead Sciences IncGILD | 2 | Strong Buy | $92.00 | N/A | Maintains | a year ago |
Eterna Therapeutics IncERNA | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Oncolytics Biotech IncONCY | 1 | Strong Buy | $3.00 | N/A | Initiates Coverage On | 2 years ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Adial Pharmaceuticals IncADIL | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aridis Pharmaceuticals IncARDS | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Kazia Therapeutics LtdKZIA | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Femasys IncFEMY | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 2 years ago |
Geovax Labs IncGOVX | 2 | Strong Buy | $90.00 | N/A | Reiterates | 2 years ago |
Synaptogenix IncSNPX | 1 | Strong Buy | $350.00 | N/A | Initiates Coverage On | 2 years ago |
Invo Bioscience IncINVO | 1 | Strong Buy | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Kiora Pharmaceuticals IncKPRX | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Acurx Pharmaceuticals IncACXP | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Protagenic Therapeutics IncPTIX | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Indaptus Therapeutics IncINDP | 2 | Strong Buy | $16.00 | N/A | Upgrades | 3 years ago |
Renovorx IncRNXT | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Omeros CorpOMER | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Stealth Biotherapeutics CorpMITO | 1 | Strong Buy | $3.00 | N/A | Initiates Coverage On | 3 years ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 3 years ago |
Enveric Biosciences IncENVB | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 3 years ago |
Mind Medicine IncMNMD | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 3 years ago |
Clene IncCLNN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Cohbar IncCWBR | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 3 years ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $7.00 | N/A | Upgrades | 3 years ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Mesoblast LtdMESO | 2 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Co Diagnostics IncCODX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Theriva Biologics IncTOVX | 2 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Cassava Sciences IncSAVA | 2 | Strong Buy | $80.00 | N/A | Maintains | 3 years ago |
Galapagos NvGLPG | 1 | Strong Buy | $170.00 | N/A | Initiates Coverage On | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 3 years ago |
Monopar TherapeuticsMNPR | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 4 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 4 years ago |
Diamedica Therapeutics IncDMAC | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 4 years ago |
Cellectar Biosciences IncCLRB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Dmk Pharmaceuticals CorpDMKPQ | 3 | Strong Buy | $105.00 | N/A | Upgrades | 4 years ago |
Aptose Biosciences IncAPTO | 1 | Strong Buy | $240.00 | N/A | Initiates Coverage On | 4 years ago |
Artelo Biosciences IncARTL | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 5 years ago |
Matinas Biopharma Holdings IncMTNB | 3 | Strong Buy | $5.00 | N/A | Maintains | 5 years ago |
Scynexis IncSCYX | 2 | Strong Buy | $40.00 | N/A | Maintains | 6 years ago |
Adma Biologics IncADMA | 1 | Strong Buy | $12.00 | N/A | Maintains | 6 years ago |
Sellas Life Sciences Group IncSLS | 1 | Strong Buy | $250.00 | N/A | Maintains | 6 years ago |
Beyondspring IncBYSI | 1 | Strong Buy | $48.00 | N/A | Maintains | 6 years ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $14.00 | N/A | Maintains | 6 years ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $12.00 | N/A | Maintains | 6 years ago |
Atossa Therapeutics IncATOS | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 6 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Bluebird Bio IncBLUE | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Imunon IncIMNN | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.